Table 1.
Description of patient population
| Characteristic | Number, n = 95 (%) |
|---|---|
| Age at diagnosis (mean, range) | 50 (26‐79) |
| Race | |
| Caucasian | 45 (47) |
| African American | 28 (29) |
| Other | 15 (15) |
| Unknown | 7 (7) |
| Ethnicity | |
| Non‐Hispanic | 83 (88) |
| Hispanic | 6 (6) |
| Unknown | 6 (6) |
| Body Mass Index (BMI) | |
| Underweight/Normal | 26 (27) |
| Overweight/Obese | 69 (73) |
| Baseline Ki67% (mean, range) | 60 (0‐95) |
| Baseline p53 (mean, range) | 44 (0‐100) |
| Baseline Grade | |
| 1 | 0 (0) |
| 2 | 5 (5) |
| 3 | 86 (95) |
| Surgery | |
| Lumpectomy | 47 (49) |
| Mastectomy | 48 (51) |
| Neoadjuvant chemotherapy | |
| Anthracycline with taxane | 63 (66) |
| Platinum based (± taxane, ± anthracycline) | 29 (31) |
| Anthracycline without taxane | 2 (2) |
| Taxanes only | 1 (1) |
| Pathologic complete response | 33 (35) |
| Recurrences, total | 33 (35) |
| Locoregional | 13 (14) |
| Distant | 20 (21) |